The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

Bioengineered Probiotic Yeast Medicines are oral, live therapeutics that express and secrete disease-targeting therapeutic molecules in situ for the treatment of gastrointestinal-related diseases.

The meetings support the company’s submission for its bioengineered corneal implants to eliminate corneal blindness.

More information: Ernest E. Moore et al, Bioengineered Human Arteries for the Repair of Vascular Injuries, JAMA Surgery (2024). DOI: 10.1001/jamasurg.2024.4893 Provided by Rutgers University ...

A new type of bioengineered blood vessel showed strong results in treating severe vascular injuries, potentially offering vascular surgeons a better alternative to synthetic grafts when patients ...

Plans for filing an IND was agreed with the FDA in a recent meeting –– Positive preclinical results of the small-diameter ATEV were recently ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

Corneal blindness affects more than 13 million people worldwide and more are waiting for corneal transplants. Human donated tissue has less than 50% success rate at five years. Other challenges ...

Susan Frey, SkinGenuity VP of Sales LARGO, FL, UNITED STATES, January 24, 2025 /EINPresswire / -- SkinGenuity, LLC, a global innovator of t ...